Forefront Analytics, LLC Surface Oncology, Inc. Transaction History

Forefront Analytics, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$0.61 - $1.03 $1,342 - $2,266	-2,200 Reduced 3.47%	61,156 $42,000
Q4 2022 Feb 13, 2023	SELL	$0.62 - $1.21 $2,158 - $4,213	-3,482 Reduced 5.21%	63,356 $51,000
Q3 2022 Nov 14, 2022	BUY	$1.05 - $2.1 $26,407 - $52,815	25,150 Added 60.33%	66,838 $70,000
Q2 2022 Aug 10, 2022	BUY	$1.42 - $3.15 $31,204 - $69,221	21,975 Added 111.47%	41,688 $71,000
Q1 2022 May 09, 2022	BUY	$2.65 - $5.08 $52,239 - $100,142	19,713 New	19,713 $62,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Forefront Analytics, LLC, based on Form 13F filings with the SEC.

Stay updated on Forefront Analytics, LLC with notifications on news.